International Journal of Pharmaceutical Sciences Review and Research, ISSN 0976-044X, 11/2015, Volume 35, Issue 1, pp. 90 - 95
Journal Article
Journal of Hepatology, ISSN 0168-8278, 10/2019
Journal Article
Advances in Environmental Biology, ISSN 1995-0756, 12/2012, Volume 6, Issue 13, pp. 4050 - 4051
Journal Article
4.
Full Text
PPARγ mediates a direct anti-angiogenic effect of ω3-PUFAs in proliferative retinopathy
Circulation research, ISSN 0009-7330, 8/2010, Volume 107, Issue 4, pp. 495 - 500
Journal Article
Military Medicine, ISSN 0026-4075, 03/2019, Volume 184, Issue Supplement_1, pp. 16 - 20
Abstract When treating large burns, autologous skin availability becomes a problem and burn surgeons rely heavily on allogenic and xenogeneic skin for...
Kerecis | wound healing | skin graft donor site | omega-3 polyunsaturated fatty acids | Skin graft | MEDICINE, GENERAL & INTERNAL | OMEGA3 WOUND MATRIX | OMEGA-3-FATTY-ACIDS | CLOSURE | DRESSINGS
Kerecis | wound healing | skin graft donor site | omega-3 polyunsaturated fatty acids | Skin graft | MEDICINE, GENERAL & INTERNAL | OMEGA3 WOUND MATRIX | OMEGA-3-FATTY-ACIDS | CLOSURE | DRESSINGS
Journal Article
1990, Food science and technology, ISBN 0824782925, Volume 37., viii, 240
Book
Pediatrics, ISSN 0031-4005, 06/2018, Volume 141, Issue 6, p. e20180094
CONTEXT: Nonpharmacologic treatments for attention-deficit/hyperactivity disorder (ADHD) encompass a range of care approaches from structured behavioral...
PSYCHOEDUCATION PROGRAM | FAMILY-SCHOOL INTERVENTION | DEFICIT HYPERACTIVITY DISORDER | GINKGO-BILOBA | RANDOMIZED CLINICAL-TRIAL | DOUBLE-BLIND | PEDIATRICS | PLACEBO-CONTROLLED TRIAL | PROSPECTIVE FOLLOW-UP | OMEGA3 FATTY-ACIDS | YOUNG-CHILDREN | Complementary Therapies | Attention Deficit Disorder with Hyperactivity - therapy | Parents - education | Humans | Fatty Acids - administration & dosage | Cognitive Behavioral Therapy | Neurofeedback | Placebos | Treatment outcome | Care and treatment | Health aspects | Analysis | Attention-deficit hyperactivity disorder
PSYCHOEDUCATION PROGRAM | FAMILY-SCHOOL INTERVENTION | DEFICIT HYPERACTIVITY DISORDER | GINKGO-BILOBA | RANDOMIZED CLINICAL-TRIAL | DOUBLE-BLIND | PEDIATRICS | PLACEBO-CONTROLLED TRIAL | PROSPECTIVE FOLLOW-UP | OMEGA3 FATTY-ACIDS | YOUNG-CHILDREN | Complementary Therapies | Attention Deficit Disorder with Hyperactivity - therapy | Parents - education | Humans | Fatty Acids - administration & dosage | Cognitive Behavioral Therapy | Neurofeedback | Placebos | Treatment outcome | Care and treatment | Health aspects | Analysis | Attention-deficit hyperactivity disorder
Journal Article
8.
ALA, fatty fish or marine n-3 fatty acids for preventing DM?: A systematic review and meta-analysis
Current Diabetes Reviews, ISSN 1573-3998, 2014, Volume 10, Issue 3, pp. 158 - 165
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 06/2016, Volume 103, Issue 6, pp. 1489 - 1496
Background: The omega-3 (n-3) long-chain polyunsaturated fatty acid (LCPUFA) docosahexaenoic acid (DHA) has proven effective at reducing fat storage in animal...
Pregnancy | Omega3 | Growth | Body composition | Maternal nutrition | ADIPOSE-TISSUE DEVELOPMENT | METAANALYSIS | pregnancy | VARIANT | body composition | OBESITY | NUTRITION & DIETETICS | omega-3 | ADIPONECTIN | DOCOSAHEXAENOIC ACID | PPAR-GAMMA | growth | maternal nutrition | YOUNG-CHILDREN | LACTATION | Body Composition | Body Mass Index | Genetic Predisposition to Disease | Prenatal Exposure Delayed Effects | Prenatal Nutritional Physiological Phenomena | Double-Blind Method | Follow-Up Studies | Humans | Child, Preschool | Genotype | Male | Pediatric Obesity - genetics | Docosahexaenoic Acids - administration & dosage | Pediatric Obesity - prevention & control | Placebos | Female | Fish Oils - administration & dosage | Dietary Supplements | PPAR gamma - genetics | Unsaturated fatty acids | Usage | Pregnant women | Analysis | Dietary supplements | Health aspects
Pregnancy | Omega3 | Growth | Body composition | Maternal nutrition | ADIPOSE-TISSUE DEVELOPMENT | METAANALYSIS | pregnancy | VARIANT | body composition | OBESITY | NUTRITION & DIETETICS | omega-3 | ADIPONECTIN | DOCOSAHEXAENOIC ACID | PPAR-GAMMA | growth | maternal nutrition | YOUNG-CHILDREN | LACTATION | Body Composition | Body Mass Index | Genetic Predisposition to Disease | Prenatal Exposure Delayed Effects | Prenatal Nutritional Physiological Phenomena | Double-Blind Method | Follow-Up Studies | Humans | Child, Preschool | Genotype | Male | Pediatric Obesity - genetics | Docosahexaenoic Acids - administration & dosage | Pediatric Obesity - prevention & control | Placebos | Female | Fish Oils - administration & dosage | Dietary Supplements | PPAR gamma - genetics | Unsaturated fatty acids | Usage | Pregnant women | Analysis | Dietary supplements | Health aspects
Journal Article
International Food Research Journal, ISSN 1985-4668, 2014, Volume 21, Issue 3, pp. 943 - 947
Journal Article
Journal of Affective Disorders, ISSN 0165-0327, 2017, Volume 224, pp. 32 - 47
Abstract Background Among emerging treatments for depressive disorders several studies suggested that n-3 polyunsaturated fatty acids (n-3PUFAs)...
Psychiatry | Pregnancy | n-3PUFAs | Post-partum | EPA | Mood disorders | Depression | Bipolar disorder | Puerperium | Omega3 | DHA | PRELIMINARY DOUBLE-BLIND | PSYCHIATRY | CLINICAL NEUROLOGY | OMEGA-3-FATTY-ACIDS SUPPLEMENTATION | PERINATAL DEPRESSION | DOCOSAHEXAENOIC ACID | ETHYL-EICOSAPENTAENOIC ACID | FISH-OIL | MAJOR DEPRESSIVE DISORDER | PLACEBO-CONTROLLED TRIAL | ALPHA-LINOLENIC ACID | Docosahexaenoic Acids - therapeutic use | Mood Disorders - drug therapy | Mood Disorders - prevention & control | Humans | Male | Treatment Outcome | Bipolar Disorder - drug therapy | Fatty Acids, Omega-3 - therapeutic use | Adult | Female | Eicosapentaenoic Acid - therapeutic use | Dietary Supplements | Depressive Disorder, Major - drug therapy | Unsaturated fatty acids | Neurosciences | Health aspects | Depression, Mental | Omega-3 fatty acids | Medical research | Medicine, Experimental
Psychiatry | Pregnancy | n-3PUFAs | Post-partum | EPA | Mood disorders | Depression | Bipolar disorder | Puerperium | Omega3 | DHA | PRELIMINARY DOUBLE-BLIND | PSYCHIATRY | CLINICAL NEUROLOGY | OMEGA-3-FATTY-ACIDS SUPPLEMENTATION | PERINATAL DEPRESSION | DOCOSAHEXAENOIC ACID | ETHYL-EICOSAPENTAENOIC ACID | FISH-OIL | MAJOR DEPRESSIVE DISORDER | PLACEBO-CONTROLLED TRIAL | ALPHA-LINOLENIC ACID | Docosahexaenoic Acids - therapeutic use | Mood Disorders - drug therapy | Mood Disorders - prevention & control | Humans | Male | Treatment Outcome | Bipolar Disorder - drug therapy | Fatty Acids, Omega-3 - therapeutic use | Adult | Female | Eicosapentaenoic Acid - therapeutic use | Dietary Supplements | Depressive Disorder, Major - drug therapy | Unsaturated fatty acids | Neurosciences | Health aspects | Depression, Mental | Omega-3 fatty acids | Medical research | Medicine, Experimental
Journal Article
12.
Full Text
Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in Muscle Damage and Function
NUTRIENTS, ISSN 2072-6643, 05/2018, Volume 10, Issue 5
Nutritional supplementation not only helps in improving and maintaining performance in sports and exercise, but also contributes in reducing exercise fatigue...
NERVOUS-SYSTEM | OXIDATIVE STRESS | unsaturated fatty acids | omega3 | muscle strength | FISH-OIL SUPPLEMENTATION | eicosapentaenoic acid | NUTRITION & DIETETICS | n-3 | RESISTANCE EXERCISE | docosahexaenoic acid | muscle damage | ECCENTRIC EXERCISE | POLYUNSATURATED FATTY-ACIDS | neuromuscular function | HEART-RATE | muscle hypertrophy | DELAYED-ONSET | OMEGA-3-FATTY-ACID SUPPLEMENTATION | UNTRAINED MEN
NERVOUS-SYSTEM | OXIDATIVE STRESS | unsaturated fatty acids | omega3 | muscle strength | FISH-OIL SUPPLEMENTATION | eicosapentaenoic acid | NUTRITION & DIETETICS | n-3 | RESISTANCE EXERCISE | docosahexaenoic acid | muscle damage | ECCENTRIC EXERCISE | POLYUNSATURATED FATTY-ACIDS | neuromuscular function | HEART-RATE | muscle hypertrophy | DELAYED-ONSET | OMEGA-3-FATTY-ACID SUPPLEMENTATION | UNTRAINED MEN
Journal Article
Nutrients, 05/2018, Volume 10, Issue 5, p. 552
Nutritional supplementation not only helps in improving and maintaining performance in sports and exercise, but also contributes in reducing exercise fatigue...
Unsaturated fatty acids | Muscle strength | N-3 | Muscle damage | Muscle hypertrophy | Docosahexaenoic acid | Omega3 | Eicosapentaenoic acid | Neuromuscular function | Damage assessment | Fish oils | Cognitive ability | Dietary supplements | Muscles | Fatigue | Inflammation | Mental depression | Fatty acids | Blood | Antioxidants | Exhaustion | Blood pressure | Endurance | Fats and oils | Supplementation | Heart diseases | muscle strength | eicosapentaenoic acid | unsaturated fatty acids | n-3 | docosahexaenoic acid | muscle damage | neuromuscular function | omega3 | muscle hypertrophy
Unsaturated fatty acids | Muscle strength | N-3 | Muscle damage | Muscle hypertrophy | Docosahexaenoic acid | Omega3 | Eicosapentaenoic acid | Neuromuscular function | Damage assessment | Fish oils | Cognitive ability | Dietary supplements | Muscles | Fatigue | Inflammation | Mental depression | Fatty acids | Blood | Antioxidants | Exhaustion | Blood pressure | Endurance | Fats and oils | Supplementation | Heart diseases | muscle strength | eicosapentaenoic acid | unsaturated fatty acids | n-3 | docosahexaenoic acid | muscle damage | neuromuscular function | omega3 | muscle hypertrophy
Journal Article
Biochimie, ISSN 0300-9084, 11/2016, Volume 130, pp. 178 - 187
Lipids are the fundamental structural components of biological membranes. For a long time considered as simple barriers segregating aqueous compartments,...
Omega3 polyunsaturated fatty acids | Aging | Lipid rafts | Neuronal membrane | Docosahexaenoic acid | Membrane remodeling | DIFFERENT REGIONS | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | SEROTONINERGIC NEUROTRANSMISSION | CHOLESTEROL-METABOLISM | COGNITIVE DECLINE | AGE-RELATED-CHANGES | POLYUNSATURATED FATTY-ACIDS | BETA-PROTEIN | Membrane Microdomains - metabolism | Humans | Membrane Microdomains - chemistry | Docosahexaenoic Acids - administration & dosage | Neuroprotective Agents - metabolism | Brain - drug effects | Brain - metabolism | Alzheimer Disease - prevention & control | Membrane Microdomains - drug effects | Models, Biological | Alzheimer Disease - metabolism | Membrane Lipids - metabolism | Membrane Proteins - metabolism | Neuroprotective Agents - administration & dosage | Docosahexaenoic Acids - metabolism | Proteins | Unsaturated fatty acids | Brain | Omega-3 fatty acids | Life Sciences
Omega3 polyunsaturated fatty acids | Aging | Lipid rafts | Neuronal membrane | Docosahexaenoic acid | Membrane remodeling | DIFFERENT REGIONS | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | SEROTONINERGIC NEUROTRANSMISSION | CHOLESTEROL-METABOLISM | COGNITIVE DECLINE | AGE-RELATED-CHANGES | POLYUNSATURATED FATTY-ACIDS | BETA-PROTEIN | Membrane Microdomains - metabolism | Humans | Membrane Microdomains - chemistry | Docosahexaenoic Acids - administration & dosage | Neuroprotective Agents - metabolism | Brain - drug effects | Brain - metabolism | Alzheimer Disease - prevention & control | Membrane Microdomains - drug effects | Models, Biological | Alzheimer Disease - metabolism | Membrane Lipids - metabolism | Membrane Proteins - metabolism | Neuroprotective Agents - administration & dosage | Docosahexaenoic Acids - metabolism | Proteins | Unsaturated fatty acids | Brain | Omega-3 fatty acids | Life Sciences
Journal Article
15.
The effect of fish oil supplement on serum antioxidant level in patient with rheumatoid arthritis
Journal of Pharmacy and Nutrition Sciences, ISSN 2223-3806, 2013, Volume 3, Issue 4, pp. 258 - 261
Journal Article
Nutrients, ISSN 2072-6643, 09/2019, Volume 11, Issue 9, p. 2158
Vitamin D and omega 3 fatty acid (ω-3) co-supplementation potentially improves type 1 diabetes (T1D) by attenuating autoimmunity and counteracting...
Pediatrics | Peptides | Clinical trials | Biochemistry | Diabetes mellitus (insulin dependent) | Glucose | Docosahexaenoic acid | Vitamin D | Restoration | Supplementation | Children | Pollutants | Drug dosages | 25-Hydroxyvitamin D | Fish oils | Diabetes mellitus | Dietary supplements | Vitamin deficiency | Regression analysis | Critical mass | Metabolism | Insulin | Fatty acids | Disease control | Beta cells | Studies | Nutrition research | Hospitals | Calciferol | Diet | Diabetes | Fats and oils | Eicosapentaenoic acid | Apoptosis | arachidonic acid | type 1 diabetes | EPA | cholecalciferol | omega3 | remission period | DHA | AA/EPA ratio | honeymoon period
Pediatrics | Peptides | Clinical trials | Biochemistry | Diabetes mellitus (insulin dependent) | Glucose | Docosahexaenoic acid | Vitamin D | Restoration | Supplementation | Children | Pollutants | Drug dosages | 25-Hydroxyvitamin D | Fish oils | Diabetes mellitus | Dietary supplements | Vitamin deficiency | Regression analysis | Critical mass | Metabolism | Insulin | Fatty acids | Disease control | Beta cells | Studies | Nutrition research | Hospitals | Calciferol | Diet | Diabetes | Fats and oils | Eicosapentaenoic acid | Apoptosis | arachidonic acid | type 1 diabetes | EPA | cholecalciferol | omega3 | remission period | DHA | AA/EPA ratio | honeymoon period
Journal Article
Journal of Affective Disorders, ISSN 0165-0327, 11/2016, Volume 205, pp. 289 - 291
Background Eicosapentaenoic acid (EPA) is suggested to be protective against posttraumatic stress disorder (PTSD) from two observational studies. We previously...
Omega3 polyunsaturated fatty acid | Clinical trial | PTSD symptom | Eicosapentaenoic acid | PSYCHIATRY | DOCOSAHEXAENOIC ACID | DISORDER | PREVENTION | FATTY-ACIDS | CLINICAL NEUROLOGY | Severity of Illness Index | Humans | Japan | Middle Aged | Arachidonic Acid - blood | Fatty Acids - analysis | Male | Eicosapentaenoic Acid - administration & dosage | Docosahexaenoic Acids - administration & dosage | Eicosapentaenoic Acid - blood | Stress Disorders, Post-Traumatic - blood | Docosahexaenoic Acids - blood | Stress Disorders, Post-Traumatic - drug therapy | Adult | Female | Erythrocyte Membrane - chemistry | Dietary Supplements | Medical policy | Unsaturated fatty acids | Analysis | Post-traumatic stress disorder | Clinical trials | Disaster victims | Omega-3 fatty acids | Public health
Omega3 polyunsaturated fatty acid | Clinical trial | PTSD symptom | Eicosapentaenoic acid | PSYCHIATRY | DOCOSAHEXAENOIC ACID | DISORDER | PREVENTION | FATTY-ACIDS | CLINICAL NEUROLOGY | Severity of Illness Index | Humans | Japan | Middle Aged | Arachidonic Acid - blood | Fatty Acids - analysis | Male | Eicosapentaenoic Acid - administration & dosage | Docosahexaenoic Acids - administration & dosage | Eicosapentaenoic Acid - blood | Stress Disorders, Post-Traumatic - blood | Docosahexaenoic Acids - blood | Stress Disorders, Post-Traumatic - drug therapy | Adult | Female | Erythrocyte Membrane - chemistry | Dietary Supplements | Medical policy | Unsaturated fatty acids | Analysis | Post-traumatic stress disorder | Clinical trials | Disaster victims | Omega-3 fatty acids | Public health
Journal Article
Iranian Journal of Obstetrics, Gynecology and Infertility, ISSN 1680-2993, 2014, Volume 17, Issue 133, pp. 22 - 28
Journal Article
European Psychiatry, ISSN 0924-9338, 2011, Volume 27, Issue 5, pp. 335 - 342
Abstract Objective To study the efficacy and safety of phosphatidylserine (PS) containing Omega3 long-chain polyunsaturated fatty acids attached to its...
Internal Medicine | Psychiatry | ADHD | Docosahexaenoic acid (DHA) | Omega3 | Eicosapentaenoic acid (EPA) | Phosphatidylserine (PS) | PSYCHOMETRIC PROPERTIES | LEARNING-DISABILITIES | METAANALYSIS | PSYCHIATRY | BEHAVIOR | OMEGA-3-FATTY-ACIDS | DIFFICULTIES QUESTIONNAIRE | MEMORY | CONNECTING PHOSPHOLIPIDS | AGED RATS | BRAIN | Double-Blind Method | Drug Administration Schedule | Humans | Phosphatidylserines - adverse effects | Male | Treatment Outcome | Attention Deficit Disorder with Hyperactivity - drug therapy | Phosphatidylserines - therapeutic use | Adolescent | Fatty Acids, Omega-3 - therapeutic use | Female | Impulsive Behavior - drug therapy | Surveys and Questionnaires | Child | Fatty Acids, Omega-3 - adverse effects | Research Design | Unsaturated fatty acids | Attention-deficit hyperactivity disorder | Clinical trials | Phospholipids | Children | Fatty acids | Psychiatric services | Omega-3 fatty acids
Internal Medicine | Psychiatry | ADHD | Docosahexaenoic acid (DHA) | Omega3 | Eicosapentaenoic acid (EPA) | Phosphatidylserine (PS) | PSYCHOMETRIC PROPERTIES | LEARNING-DISABILITIES | METAANALYSIS | PSYCHIATRY | BEHAVIOR | OMEGA-3-FATTY-ACIDS | DIFFICULTIES QUESTIONNAIRE | MEMORY | CONNECTING PHOSPHOLIPIDS | AGED RATS | BRAIN | Double-Blind Method | Drug Administration Schedule | Humans | Phosphatidylserines - adverse effects | Male | Treatment Outcome | Attention Deficit Disorder with Hyperactivity - drug therapy | Phosphatidylserines - therapeutic use | Adolescent | Fatty Acids, Omega-3 - therapeutic use | Female | Impulsive Behavior - drug therapy | Surveys and Questionnaires | Child | Fatty Acids, Omega-3 - adverse effects | Research Design | Unsaturated fatty acids | Attention-deficit hyperactivity disorder | Clinical trials | Phospholipids | Children | Fatty acids | Psychiatric services | Omega-3 fatty acids
Journal Article
International Journal of Food Science & Technology, ISSN 0950-5423, 04/2017, Volume 52, Issue 4, pp. 1057 - 1063
Summary Health benefits of polyunsaturated oils are well known; nevertheless, incorporating these oils into food/feed products is not possible due to their...
oils | Microencapsulation | omega3 | FATTY-ACID-COMPOSITION | OMEGA-3-FATTY-ACIDS | FOOD SCIENCE & TECHNOLOGY | ENCAPSULATION | DOCOSAHEXAENOIC ACID | GROWTH | OMEGA-3 | FISH-OIL | OXIDATIVE STABILITY | SKIN | HEALTH | Seafood industry | Cellulose | Cosmetics | Food science | Fish oils | Feeds | Fatty acids | Antioxidants | Encapsulation | Stability | Drying oils | Fish | Foods | Microparticles
oils | Microencapsulation | omega3 | FATTY-ACID-COMPOSITION | OMEGA-3-FATTY-ACIDS | FOOD SCIENCE & TECHNOLOGY | ENCAPSULATION | DOCOSAHEXAENOIC ACID | GROWTH | OMEGA-3 | FISH-OIL | OXIDATIVE STABILITY | SKIN | HEALTH | Seafood industry | Cellulose | Cosmetics | Food science | Fish oils | Feeds | Fatty acids | Antioxidants | Encapsulation | Stability | Drying oils | Fish | Foods | Microparticles
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.